PRF Technologies (PRFX) Net Income (2020 - 2024)
PRF Technologies' (PRFX) quarterly Net Income came in at $5.3 million in Q2 2024, up 178.28% YoY from $1.9 million in Q3 2023, and up 196.64% on a QoQ basis from -$5.5 million in Q1 2024.
PRF Technologies (PRFX) Net Income (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Net Income data on file, last reported at $5.3 million in Q2 2024.
- Quarterly Net Income rose 178.28% year-over-year to $5.3 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was $5.3 million (up 148.7% YoY) and the FY2025 annual result came in at -$5.0 million, up 66.16% from the prior year.
- Net Income climbed to $5.3 million in Q2 2024, from -$5.5 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $9.3 million in Q3 2021 to a low of -$10.7 million in Q4 2023.
- A 5-year average of -$1.5 million and a median of -$1.7 million in 2021 frame the typical range for Net Income.
- Annual changes were most pronounced in 2021 — Net Income slumped 355.02% — and 2022, when it jumped 406.35%.
- Tracing PRFX's Net Income over 5 years: stood at -$4.2 million in 2020, then plunged by 65.42% to -$6.9 million in 2021, then declined by 28.75% to -$8.9 million in 2022, then dropped by 21.01% to -$10.7 million in 2023, then jumped by 149.54% to $5.3 million in 2024.
- The last three Net Income figures came in at $5.3 million (Q2 2024), -$5.5 million (Q1 2024), and -$10.7 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 5.32 Mn |
| Mar 31, 2024 | -5.51 Mn |
| Dec 31, 2023 | -10.74 Mn |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | -6.80 Mn |
| Mar 31, 2023 | 2.31 Mn |
| Dec 31, 2022 | -8.88 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 5.21 Mn |
| Mar 31, 2022 | -1.69 Mn |
| Dec 31, 2021 | -6.89 Mn |
| Sep 30, 2021 | 9.26 Mn |
| Jun 30, 2021 | -1.70 Mn |
| Mar 31, 2021 | -2.04 Mn |
| Dec 31, 2020 | -4.17 Mn |
| Sep 30, 2020 | -5.02 Mn |
| Jun 30, 2020 | 667,000.00 |
| Mar 31, 2020 | 1.30 Mn |